Acute stroke is also commonly called a cerebrovascular accident which is not a term preferred by most stroke neurologists. Stroke is NOT an accident. The better and more meaningful term is "brain attack", similar in significance to "heart attack". Acute stroke is defined as the acute onset of focal neurological findings in a vascular territory as a result of underlying cerebrovascular disease. In the United States, there are 800,000 new strokes every year. There is one new stroke every 40 seconds. Stroke is the 5th leading cause of death and the first leading cause of disability. There are two main types of strokes. The commoner type is an ischemic stroke, caused by interruption of blood flow to a certain area of the brain. Ischemic stroke accounts for 85% of all acute strokes. 15% of acute strokes are hemorrhagic strokes which are caused by bursting of a blood vessel i.e. acute hemorrhage. There are two main types of hemorrhagic strokes, intracerebral hemorrhage (ICH) and subarachnoid hemorrhage which accounts for about 5% of all strokes.
According to the TOAST classification, there are four main types of ischemic strokes. These are large vessel atherosclerosis, small vessel diseases (lacunar infarcts), cardioembolic strokes and cryptogenic strokes. Each of these has different causes and pathophysiology. Regardless o the type of stroke, it is important to know that with each minute of large vessel ischemic stroke untreated, close to two million neurons die. This is the most important "time is brain" concept in understanding acute stroke and its treatment.
There are numerous causes of stroke, such as prolonged hypertension, arteriosclerosis, and emboli that have formed in the heart as a result of atrial fibrillation or rheumatic heart disease. In younger patients, the possible list of causes may be broadened to include clotting disorders, cervical arterial dissection, and various forms of vasculitis. In the event of a possible stroke presentation, a precise history and physical must be performed alongside emergent neurological imaging before administering any form of treatment. With early, focused treatment based on the stroke etiology, rehabilitation programs, and long-term lifestyle changes, one can maximize his/her chances for a meaningful recovery.
There is a multitude of etiologies that can lead to a stroke. Some of the most common risk factors include hypertension, diabetes mellitus, hypercholesterolemia, physical inactivity, obesity, genetics, and smoking. Cerebral emboli commonly originate from the heart, especially in patients with preexisting heart arrhythmias (atrial fibrillation), valvular disease, structural defects (atrial and ventricular septal defects) and chronic rheumatic heart disease. Emboli may lodge in areas of preexisting stenosis. Alcohol intake has a J-shaped relationship with ischemic stroke. Mild to moderate drinking carries a slightly lower risk of ischemic stroke yet heavier drinking increases the risk drastically. Alcohol intake increases the risk of hemorrhagic stroke in a near linear relationship.
Strokes that occur in small vessels(lacunar infarcts) are most commonly caused by chronic, uncontrolled hypertension resulting in the pathological entity of lipohyalinosis and arteriolosclerosis. These strokes occur in the basal ganglia, internal capsule, thalamus, and pons. Uncontrolled hypertension in these areas can also lead to hypertensive intracerebral hemorrhages (ICH).
About 15% of all strokes are classified as hemorrhagic, with the etiology being the most commonly uncontrolled hypertension. Other causes of hemorrhagic strokes include cerebral amyloid angiopathy, a disease in which amyloid plaques deposit in small and medium vessels, which causes vessels to become rigid and more vulnerable to tears. Deposition can occur anywhere, but they occur most commonly on the surfaces of the frontal and parietal lobes. The structural integrity of vessels is another important consideration in hemorrhagic stroke etiology, with aneurysms, arteriovenous malformations, cavernous malformations, capillary telangiectasias, venous angiomas, and vasculitis being more common reasons for stroke.
Atherosclerosis is the most common and important underlying pathology which leads to the formation of an atherothrombotic plaque secondary to low-density lipoprotein cholesterol (LDL) build up in the arteries supplying the brain. These plagues may block or decrease the diameter of the neck or intracranial arteries resulting in distal ischemia of the brain. More commonly they may also rupture. Plague rupture leads to exposure of the underlying cholesterol crystals which attract platelets and fibrin. Release of fibrin-platelet rich emboli causes strokes in the distal arterial territories via an artery-to-artery embolic mechanism. The nature of the cardiac source of emboli depends on the underlying cardiac problem. In atrial fibrillation, clots tend to be formed in the left atrium. These are red blood cell rich clots. There may be tumor emboli in left atrial myxoma and bacterial clumps from vegetations when emboli arise during infective endocarditis.
When an arterial blockage occurs, the immediately adjacent neurons lose their supply of oxygen and nutrients. The inability to go through aerobic metabolism and produce ATP causes the Na+/K+ ATPase pumps to fail, leading to an accumulation of Na+ inside the cells and K+ outside the cells. The Na+ ion accumulation leads to cell depolarization and subsequent glutamate release. Glutamate opens NMDA and AMPA receptors and allows for calcium ions to flow into the cells. A continuous flow of calcium leads to continuous neuronal firing and eventual cell death via excitotoxicity.
In the first 12 hours, there are no significant macroscopic changes. There is cytotoxic edema related to energy production failure with neuronal cellular swelling. This early infarction state can be visualized by diffusion-weighted MRI which shows restricted diffusion as a result of neuronal cellular swelling. Six to twelve hours after the stroke, vasogenic edema develops. This phase may be best visualized with FLAIR sequence MRI. Both cytotoxic and vasogenic edema causes swelling of the infarcted area and increases in intracranial pressure. These are followed by the invasion of phagocytic cells which try to clear away the dead cells. Extensive phagocytosis causes softening and liquefaction of the affected brain tissues, with peak liquefaction occurring 6 months post-stroke. Several months after a stroke, astrocytes form a dense network of glial fibers mixed with capillaries and connective tissue.
Hemorrhagic strokes lead to a similar type of cellular dysfunction and concerted events of repair with the addition of blood extravasation and resorption.
Time is brain! An expedited yet thorough history is an absolutely critical first step toward making a diagnosis. A stroke should be high on the differential for a patient presenting with sudden, focal neurological deficits and/or altered level of consciousness. Based on clinical presentation alone, it is difficult to differentiate between a hemorrhagic or ischemic stroke on a consistent basis. Headache at the onset and/or altered level of awareness does indicate more likely a hemorrhage yet a small intracerebral hemorrhage can present clinically exactly like a deep hemisphere ischemic infarction. The signs and symptoms elicited from the history and physical can aid in localizing the affected region. Common signs and symptoms include hemiparesis, sensory deficits, diplopia, dysarthria, and facial droop. Strokes in the posterior circulation present with a sudden onset of ataxia and vertigo. Symptoms commonly attributed to increased intracranial pressure, such as nausea, vomiting, headache, and blurred or double vision, may also provide evidence supporting a hemorrhagic stroke. In addition to gathering information about the symptoms, one needs to establish the time of their onset to decide subsequent therapy once the diagnosis of ischemic stroke is confirmed.
A neurological exam is performed to ascertain stroke location, establish baseline function upon hospital admission, rule out a transient ischemic attack (TIA) and other stroke mimickers, and deduce potential comorbidities. It is composed of testing cranial nerve function, the range of motion and muscle strength, sensory integrity, vibratory sense, cerebellar function, gait, language, mental status, and level of consciousness. Baseline function is determined via the National Institutes of Health Stroke Scale (NIHSS), which focuses on the level of consciousness, visual and motor function, sensation and neglect, cerebellar function, and language capabilities.
In addition to the neurological exam, the neck is examined to rule out signs of meningitis via palpation of the paraspinal musculature and testing the range of motion. Presence of a carotid bruit indicates underlying atherosclerosis. Besides testing extraocular muscle function and the visual field for visual defects, a fundus examination is performed to check for hypertensive changes, retinal hemorrhage, and emboli. A peripheral vasculature exam includes palpation of the carotid, radial, femoral, and posterior tibial pulses. A cardiac exam is also performed to detect murmurs, rubs, gallops, or arrhythmias.
Emergency CT without contrast is the most important first diagnostic tool utilized to confirm the diagnosis and rule out any bleed or a hemorrhagic stroke. Based on the CT results and symptom onset, a patient may be a candidate for fibrinolytic therapy. A diffusion-weighted MRI is most diagnostic of acute ischemic infarction. It may confirm the diagnosis and also reveal the size and location of the infarction. It is not considered to be the first line imaging due to the time needed to obtain the images and the relative lack of availability. Other MRI protocols especially the diffusion-perfusion mismatch describes the area of tissue at risk ("penumbra") that can be saved with early treatment and identifies patients that benefit from reperfusion therapy beyond the initial 4.5 - 6 hours of an acute ischemic stroke. A cardiac pacemaker is still an absolute contraindication for an MRI. A CT angiogram aids in localizing the blockage in the vasculature. It can identify patients with large vessel occlusion for interventional thrombectomy therapy. CT perfusion studies may also identify the ischemic core and penumbra mismatch which may be a guide to a decision on revascularization beyond the 6 hours window. Doppler studies can also be utilized to determine the degree of carotid stenosis.
Labs are drawn to determine the patient’s baseline health and provide potential clues toward stroke etiology. Some of the basic labs include a metabolic panel, complete blood count with differential, lipid profile, hemoglobin A1c (HbA1c), blood urine nitrogen (BUN), creatinine, albumin, and glomerular filtration rate (GFR). Among these, random blood sugar, platelet count and PT/PTT are important to determine if the patient is an IV thrombolysis candidate. In younger patients presenting with stroke symptoms, other labs that might be ordered include a coagulation panel, rheumatoid factor (RF), antinuclear antibodies (ANA), and other markers for vasculitis.
An ECG, echocardiogram and prolonged ECG monitoring may be indicated to rule out a cardiac etiology especially atrial fibrillation in "cryptogenic strokes". An EEG may also be warranted to rule out a post-seizure state.
Before any treatment can be administered, the patient must be assessed for stable airway, breathing, and circulation. The next step is to assess if he/she is a candidate for alteplase (rt-PA). The exclusion criteria are based on guidelines from the American Heart Association/American Stroke Association. Fibrinolytic therapy aims to dissolve the clot and restore blood flow to the affected regions. The fibrinolytic must be administered within 3 to 4.5 hours after symptom onset to be effective, depending on exclusion criteria. As with the treatment of myocardial infarction and sepsis care, during a stroke, the "time is brain" approach is important and requires a fast and team-based treatment approach. Mobile stroke units and telemedicine have evolved to reduce time to treatment window. The time frame for treatment has recently been expanded due to the option of endovascular treatment.
A notable potential complication after fibrinolytic therapy is hemorrhage. Hemorrhagic transformation is classified as hemorrhagic infarction and parenchymal hematoma, each with 2 subsets. Hemorrhagic infarctions occur more often than parenchymal hematomas. Predictive factors for the occurrence of this complication include increased infarction area, gray matter location, atrial fibrillation, and cerebral embolism, acute hyperglycemia, low platelet count, and poor collateral circulation.
In recent years there are significant advancements in acute stroke care. Multiple trials published in 2015 showed that endovascular thrombectomy in the first six hours is much better than standard medical care in patients with large vessel occlusion in the anterior circulation. These benefits sustained irrespective of geographical location and patient characteristics. 
Again in 2018, a significant paradigm shift happened in stroke care. DAWN and DEFUSE 3 trials showed significant benefits of Endovascular thrombectomy in patients with large vessel occlusion in the arteries of the proximal anterior circulation. This trial extended stroke window up to 16 -24 hours in selected patients using perfusion imaging. Due to this, we can treat more patients even up to 16 - 24 hours. 
Within 24 to 48 hours of symptoms onset, patients should be placed on antiplatelet therapy, aspirin orally. Blood pressure should be maintained slightly elevated for the first few days after a stroke to improve perfusion to the peri-infarction zones. Blood pressure should also be lowered by no more than 15% if diastolic blood pressure is over 220 mm Hg or if systolic blood pressure is over 120 mm Hg. BP does need to be lower than 180/110 for IV Alteplase therapy. Comorbidities also need to be addressed and managed during the patient’s hospital stay.
Patients are admitted to the stroke unit that is equipped and trained to treat and care for people with stroke. The superiority of stroke units compared to non-specialised units has been proven in studies. Acute stroke treatment is best performed with a team approach involving the stroke neurologist, an interventional neuroradiologist, speech pathologist, physical therapist, occupational therapist, pharmacist, social worker, and the nursing care team. General care of a patient with acute stroke will include BP care as described above, swallowing evaluation and aspiration prevention, IV fluid with isotonic fluids, avoid and treat fever aggressively, treat hyperglycemia, prevent infection and DVT prophylaxis and early evaluation and plan for subsequent rehabilitation.
The differential diagnosis is broad and can include stroke mimics such as TIA, metabolic derangement (in other words, hypoglycemia, hyponatremia), a hemiplegic migraine, infection, brain tumor, syncope, and conversion disorder.
The prognosis after a stroke is multifactorial, with patient age, stroke severity, stroke etiology, infarct location, and associated comorbidities being significant contributing factors. Stroke complications can also impact a patient’s prognosis. Common complications include pneumonia, deep vein thrombosis, urinary tract infections, and pulmonary embolism. However, patients who do not experience any complications within the first week tend to experience steady neurological improvement. The majority of patients experience the most improvement during the first 3 to 6 months after a stroke.
"Time is brain" is the most important concept in acute stroke care.
"FAST" approach is most important in educating the public about acute stroke. It stands for facial asymmetry, unilateral arm weakness or drift, speech problem and time - note the time of onset and call 911 immediately.
Non-contrast CT head is the imaging modality of choice in acute stroke.
IV thrombolysis within 3 - 4.5 hours with slightly different contraindications.
Mechanical thrombectomy in Primary Stroke Center with thrombectomy capability or Comprehensive Stroke Centers for anterior circulation ischemic strokes within 6 hours for large vessel occlusion.
Thrombectomy may be extended for wake-up strokes and onset within 16 - 24 hours by selecting patients with a large mismatch of their infarct core and ischemic penumbra.
Education of the public and Emergency Medical Services(EMS) are extremely important in improving stroke outcomes. The stroke system of care varies among different counties depending on the availability of accredited primary or comprehensive stroke centers and the different EMS guidelines about where to send the patients to.
During the time-dependent early stroke phase and rehabilitation, stroke care involves an interprofessional team to manage the disease. Once the diagnosis of stroke is made, the patient may need extensive physical rehabilitation, speech therapy and/or a dietary consult. For those who recover function within 3 months, the prognosis is good, but for those with residual neurological deficits, the outcome is guarded.
Secondary prevention after an acute stroke depends on the underlying stroke mechanism. An acute ischemic stroke due to an underlying symptomatic extracranial large artery stenosis of >70% is best treated with carotid endarterectomy in most cases and stenting in some selected cases. A cardiac source of cerebral embolism, most commonly due to atrial fibrillation is best treated with long term oral anticoagulation. A small vessel lacunar infarct is best prevented with an antiplatelet agent and good control of hypertension. Finally, a combination multimodality approach including an antiplatelet agent, good BP control, good blood sugar control, high dose statin, healthy diet, weight control, tobacco quitting and healthy lifestyle are able to prevent at least 80% of subsequent strokes.
|||Zafar F,Tariq W,Shoaib RF,Shah A,Siddique M,Zaki A,Assad S, Frequency of Ischemic Stroke Subtypes Based on Toast Classification at a Tertiary Care Center in Pakistan. Asian journal of neurosurgery. 2018 Oct-Dec [PubMed PMID: 30459853]|
|||Hankey GJ, Stroke. Lancet (London, England). 2017 Feb 11 [PubMed PMID: 27637676]|
|||Sarti C,Kaarisalo M,Tuomilehto J, The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients. Drugs & aging. 2000 Jul [PubMed PMID: 10933514]|
|||Shi Y,Wardlaw JM, Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke and vascular neurology. 2016 Sep [PubMed PMID: 28959468]|
|||Hanley DF,Awad IA,Vespa PM,Martin NA,Zuccarello M, Hemorrhagic stroke: introduction. Stroke. 2013 Jun [PubMed PMID: 23709734]|
|||Benjamin EJ,Blaha MJ,Chiuve SE,Cushman M,Das SR,Deo R,de Ferranti SD,Floyd J,Fornage M,Gillespie C,Isasi CR,Jiménez MC,Jordan LC,Judd SE,Lackland D,Lichtman JH,Lisabeth L,Liu S,Longenecker CT,Mackey RH,Matsushita K,Mozaffarian D,Mussolino ME,Nasir K,Neumar RW,Palaniappan L,Pandey DK,Thiagarajan RR,Reeves MJ,Ritchey M,Rodriguez CJ,Roth GA,Rosamond WD,Sasson C,Towfighi A,Tsao CW,Turner MB,Virani SS,Voeks JH,Willey JZ,Wilkins JT,Wu JH,Alger HM,Wong SS,Muntner P, Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7 [PubMed PMID: 28122885]|
|||Krishnamurthi RV,Moran AE,Feigin VL,Barker-Collo S,Norrving B,Mensah GA,Taylor S,Naghavi M,Forouzanfar MH,Nguyen G,Johnson CO,Vos T,Murray CJ,Roth GA, Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study. Neuroepidemiology. 2015 [PubMed PMID: 26505983]|
|||Xing C,Arai K,Lo EH,Hommel M, Pathophysiologic cascades in ischemic stroke. International journal of stroke : official journal of the International Stroke Society. 2012 Jul [PubMed PMID: 22712739]|
|||Chung AG,Frye JB,Zbesko JC,Constantopoulos E,Hayes M,Figueroa AG,Becktel DA,Antony Day W,Konhilas JP,McKay BS,Nguyen TV,Doyle KP, Liquefaction of the Brain following Stroke Shares a Similar Molecular and Morphological Profile with Atherosclerosis and Mediates Secondary Neurodegeneration in an Osteopontin-Dependent Mechanism. eNeuro. 2018 Sep-Oct [PubMed PMID: 30417081]|
|||Mărgăritescu O,Mogoantă L,Pirici I,Pirici D,Cernea D,Mărgăritescu C, Histopathological changes in acute ischemic stroke. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. 2009 [PubMed PMID: 19690757]|
|||Aronowski J,Zhao X, Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011 Jun [PubMed PMID: 21527759]|
|||Yew KS,Cheng E, Acute stroke diagnosis. American family physician. 2009 Jul 1 [PubMed PMID: 19621844]|
|||Kwah LK,Diong J, National Institutes of Health Stroke Scale (NIHSS). Journal of physiotherapy. 2014 Mar [PubMed PMID: 24856948]|
|||Spader HS,Grossberg JA,Haas RA,Soares GM, Fundamentals of the neurologic examination for patients undergoing central nervous system interventional procedures. Seminars in interventional radiology. 2013 Sep [PubMed PMID: 24436545]|
|||Motta M,Ramadan A,Hillis AE,Gottesman RF,Leigh R, Diffusion-perfusion mismatch: an opportunity for improvement in cortical function. Frontiers in neurology. 2014 [PubMed PMID: 25642208]|
|||Heiss WD, The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011. Cerebrovascular diseases (Basel, Switzerland). 2011 [PubMed PMID: 21921593]|
|||Birenbaum D,Bancroft LW,Felsberg GJ, Imaging in acute stroke. The western journal of emergency medicine. 2011 Feb [PubMed PMID: 21694755]|
|||Kisialiou A,Pelone G,Carrizzo A,Grillea G,Trimarco V,Marino M,Bartolo M,De Nunzio AM,Grella R,Landolfi A,Puca A,Colonnese C,Vecchione C, Blood biomarkers role in acute ischemic stroke patients: higher is worse or better? Immunity & ageing : I & A. 2012 Oct 31 [PubMed PMID: 23110752]|
|||Loftspring MC,Kissela BM,Flaherty ML,Khoury JC,Alwell K,Moomaw CJ,Kleindorfer DO,Woo D,Adeoye O,Ferioli S,Broderick JP,Khatri P, Practice Patterns for Acute Ischemic Stroke Workup: A Longitudinal Population-Based Study. Journal of the American Heart Association. 2017 Jun 23 [PubMed PMID: 28645938]|
|||Saver JL, Time is brain--quantified. Stroke. 2006 Jan [PubMed PMID: 16339467]|
|||Bowry R,Grotta JC, Bringing Emergency Neurology to Ambulances: Mobile Stroke Unit. Seminars in respiratory and critical care medicine. 2017 Dec [PubMed PMID: 29262428]|
|||Demaerschalk BM,Miley ML,Kiernan TE,Bobrow BJ,Corday DA,Wellik KE,Aguilar MI,Ingall TJ,Dodick DW,Brazdys K,Koch TC,Ward MP,Richemont PC, Stroke telemedicine. Mayo Clinic proceedings. 2009 [PubMed PMID: 19121244]|
|||Weimar C,Ziegler A,König IR,Diener HC, Predicting functional outcome and survival after acute ischemic stroke. Journal of neurology. 2002 Jul [PubMed PMID: 12140674]|
|||Wang W,Li M,Chen Q,Wang J, Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers. Molecular neurobiology. 2015 Dec [PubMed PMID: 25367883]|
|||Goyal M,Menon BK,van Zwam WH,Dippel DW,Mitchell PJ,Demchuk AM,Dávalos A,Majoie CB,van der Lugt A,de Miquel MA,Donnan GA,Roos YB,Bonafe A,Jahan R,Diener HC,van den Berg LA,Levy EI,Berkhemer OA,Pereira VM,Rempel J,Millán M,Davis SM,Roy D,Thornton J,Román LS,Ribó M,Beumer D,Stouch B,Brown S,Campbell BC,van Oostenbrugge RJ,Saver JL,Hill MD,Jovin TG, Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet (London, England). 2016 Apr 23; [PubMed PMID: 26898852]|
|||Nogueira RG,Jadhav AP,Haussen DC,Bonafe A,Budzik RF,Bhuva P,Yavagal DR,Ribo M,Cognard C,Hanel RA,Sila CA,Hassan AE,Millan M,Levy EI,Mitchell P,Chen M,English JD,Shah QA,Silver FL,Pereira VM,Mehta BP,Baxter BW,Abraham MG,Cardona P,Veznedaroglu E,Hellinger FR,Feng L,Kirmani JF,Lopes DK,Jankowitz BT,Frankel MR,Costalat V,Vora NA,Yoo AJ,Malik AM,Furlan AJ,Rubiera M,Aghaebrahim A,Olivot JM,Tekle WG,Shields R,Graves T,Lewis RJ,Smith WS,Liebeskind DS,Saver JL,Jovin TG, Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. The New England journal of medicine. 2018 Jan 4; [PubMed PMID: 29129157]|
|||Thomalla G,Gerloff C, Acute imaging for evidence-based treatment of ischemic stroke. Current opinion in neurology. 2019 May 20 [PubMed PMID: 31116116]|
|||Musuka TD,Wilton SB,Traboulsi M,Hill MD, Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2015 Sep 8 [PubMed PMID: 26243819]|
|||Sun Y,Paulus D,Eyssen M,Maervoet J,Saka O, A systematic review and meta-analysis of acute stroke unit care: what's beyond the statistical significance? BMC medical research methodology. 2013 Oct 28 [PubMed PMID: 24164771]|
|||Allen CM, Differential diagnosis of acute stroke: a review. Journal of the Royal Society of Medicine. 1984 Oct [PubMed PMID: 6387114]|
|||Clarke DJ,Forster A, Improving post-stroke recovery: the role of the multidisciplinary health care team. Journal of multidisciplinary healthcare. 2015 [PubMed PMID: 26445548]|
|||Wein T,Lindsay MP,Côté R,Foley N,Berlingieri J,Bhogal S,Bourgoin A,Buck BH,Cox J,Davidson D,Dowlatshahi D,Douketis J,Falconer J,Field T,Gioia L,Gubitz G,Habert J,Jaspers S,Lum C,McNamara Morse D,Pageau P,Rafay M,Rodgerson A,Semchuk B,Sharma M,Shoamanesh A,Tamayo A,Smitko E,Gladstone DJ, Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017. International journal of stroke : official journal of the International Stroke Society. 2018 Jun [PubMed PMID: 29171361]|